Overview of extensively employed polymeric carriers in solid dispersion technology AR Nair, YD Lakshman, VSK Anand, KSN Sree, K Bhat, SJ Dengale AAPS PharmSciTech 21, 1-20, 2020 | 122 | 2020 |
Considerations for the selection of co-formers in the preparation of co-amorphous formulations DL Yarlagadda, VSK Anand, AR Nair, KSN Sree, SJ Dengale, K Bhat International Journal of Pharmaceutics 602, 120649, 2021 | 39 | 2021 |
Influence of preparation methods on physicochemical and pharmacokinetic properties of co-amorphous formulations: The case of co-amorphous atorvastatin: Naringin A Nair, R Varma, K Gourishetti, K Bhat, S Dengale Journal of Pharmaceutical Innovation 15, 365-379, 2020 | 35 | 2020 |
The relevance of co-amorphous formulations to develop supersaturated dosage forms: In-vitro, and ex-vivo investigation of Ritonavir-Lopinavir co-amorphous materials VSK Anand, SD Sakhare, KSN Sree, AR Nair, KR Varma, K Gourishetti, ... European Journal of Pharmaceutical Sciences 123, 124-134, 2018 | 29 | 2018 |
Polymeric solid dispersion Vs co-amorphous technology: A critical comparison SKA Vullendula, AR Nair, DL Yarlagadda, KSN Sree, K Bhat, SJ Dengale Journal of Drug Delivery Science and Technology 78, 103980, 2022 | 9 | 2022 |
A computational-based approach to fabricate Ceritinib co-amorphous system using a novel co-former Rutin for bioavailability enhancement DL Yarlagadda, VSK Anand, AR Nair, SJ Dengale, S Pandiyan, ... European Journal of Pharmaceutics and Biopharmaceutics 190, 220-230, 2023 | 5 | 2023 |
Physicochemical interaction of rifampicin and ritonavir-lopinavir solid dispersion: an in-vitro and ex-vivo investigation AR Nair, SKA Vullendula, DL Yarlagadda, B Bheemisetty, SJ Dengale, ... Drug Development and Industrial Pharmacy 50 (3), 192-205, 2024 | | 2024 |